Advertisement
HSIC vs YI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSIC is a Hold and YI is a Hold.
HSIC in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 17, 2026
HSIC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 24 of 34 cases where HSIC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 71%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on HSIC as a result. In 54 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.
The Moving Average Convergence Divergence (MACD) for HSIC just turned positive on October 13, 2026. Looking at past instances where HSIC's MACD turned positive, the stock continued to rise in 27 of 46 cases over the following month. The odds of a continued upward trend are 59%.
Following a +1.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where HSIC advanced for three days, in 162 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
HSIC moved below its 50-day moving average on September 15, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HSIC crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSIC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
The Aroon Indicator for HSIC entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. HSIC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.036) is normal, around the industry mean (2.488). P/E Ratio (25.070) is within average values for comparable stocks, (39.020). Projected Growth (PEG Ratio) (1.715) is also within normal values, averaging (2.016). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (0.750) is also within normal values, averaging (4.260).
The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 84 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSIC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.
Momentum Indicator for YI turns negative, indicating new downward trend
YI saw its Momentum Indicator move below the 0 level on October 01, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 77 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for YI turned negative on October 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 37 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
YI moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for YI crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where YI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for YI entered a downward trend on September 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where YI's RSI Indicator exited the oversold zone, 36 of 45 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where YI advanced for three days, in 185 of 242 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
YI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.668) is normal, around the industry mean (2.488). YI has a moderately low P/E Ratio (0.000) as compared to the industry average of (39.020). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.016). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (0.017) is also within normal values, averaging (4.260).
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. YI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. YI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.
HSIC | YI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 87 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 62 Fair valued | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 84 | 100 | |
SMR RATING 1..100 | 63 | 100 | |
PRICE GROWTH RATING 1..100 | 47 | 83 | |
P/E GROWTH RATING 1..100 | 25 | 100 | |
SEASONALITY SCORE 1..100 | 65 | 13 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HSIC's Valuation (62) in the Medical Distributors industry is in the same range as YI (74) in the Drugstore Chains industry. This means that HSIC’s stock grew similarly to YI’s over the last 12 months.
HSIC's Profit vs Risk Rating (84) in the Medical Distributors industry is in the same range as YI (100) in the Drugstore Chains industry. This means that HSIC’s stock grew similarly to YI’s over the last 12 months.
HSIC's SMR Rating (63) in the Medical Distributors industry is somewhat better than the same rating for YI (100) in the Drugstore Chains industry. This means that HSIC’s stock grew somewhat faster than YI’s over the last 12 months.
HSIC's Price Growth Rating (47) in the Medical Distributors industry is somewhat better than the same rating for YI (83) in the Drugstore Chains industry. This means that HSIC’s stock grew somewhat faster than YI’s over the last 12 months.
HSIC's P/E Growth Rating (25) in the Medical Distributors industry is significantly better than the same rating for YI (100) in the Drugstore Chains industry. This means that HSIC’s stock grew significantly faster than YI’s over the last 12 months.
| HSIC | YI | |
|---|---|---|
| RSI ODDS (%) | N/A | 6 days ago 80% |
| Stochastic ODDS (%) | 2 days ago 65% | 2 days ago 80% |
| Momentum ODDS (%) | 2 days ago 55% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 59% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 53% | 2 days ago 73% |
| TrendMonth ODDS (%) | 2 days ago 54% | 2 days ago 90% |
| Advances ODDS (%) | 2 days ago 55% | 22 days ago 76% |
| Declines ODDS (%) | 10 days ago 56% | 2 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 71% | 7 days ago 67% |
| Aroon ODDS (%) | 2 days ago 42% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HSIC’s FA Score shows that 1 FA rating(s) are green while YI’s FA Score has 0 green FA rating(s).
- HSIC’s FA Score: 1 green, 4 red.
- YI’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HSIC’s TA Score shows that 4 TA indicator(s) are bullish while YI’s TA Score has 4 bullish TA indicator(s).
- HSIC’s TA Score: 4 bullish, 5 bearish.
- YI’s TA Score: 4 bullish, 6 bearish.
Price Growth
HSIC (@Medical Distributors) experienced а +0.22% price change this week, while YI (@Medical Distributors) price change was +0.16% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was +1.14%. For the same industry, the average monthly price growth was +2.85%, and the average quarterly price growth was -20.81%.
Reported Earning Dates
HSIC is expected to report earnings on Nov 03, 2026.
YI is expected to report earnings on Nov 26, 2026.
Industries' Descriptions
@Medical Distributors (+1.14% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IUSB | 44.19 | 0.04 | +0.09% |
| iShares Core Total USD Bond Market ETF (IUSB) | |||
| SH | 31.83 | 0.01 | +0.03% |
| ProShares Short S&P500 (SH) | |||
| GOCT | 42.95 | -0.01 | -0.02% |
| FT Vest U.S. Equity Moderate Buffer ETF - October (GOCT) | |||
| GTR | 27.43 | -0.02 | -0.07% |
| WisdomTree Target Range Fund (GTR) | |||
| GGTL | 40.38 | -0.58 | -1.42% |
| Gabelli Global Technology Leaders ETF (GGTL) | |||
YI and
Correlation & Price change
A.I.dvisor tells us that YI and LFMD have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that YI and LFMD's prices will move in lockstep.